NDC 72572-076-01 - Clindamycin in 5 Percent Dextrose
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72572-076
- Requested NDC
- 72572-076-01
- Package NDCs from labels
- 72572-076-01, 72572-076-24
- Manufacturer
- Civica, Inc.
- Effective date
- 2026-04-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clindamycin in 5% Dextrose Injection Rx Only | Civica, Inc. | 2026-04-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72572-076-01 | Clindamycin in 5 Percent Dextrose | 50 mL in 1 BAG | INJECTION, SOLUTION | 50 | 3 | |
| 72572-076-24 | Clindamycin in 5 Percent Dextrose | 24 in 1 CARTON | INJECTION, SOLUTION | 24 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72572-076-01 | ML - Milliliter | 72572-076 | 90510efd-05ba-456a-809a-86aa90e72794 | 1 | 2022-02-07 |
| 72572-076-24 | ML - Milliliter | 72572-076 | 256a03b0-277b-4583-8b42-d2da1367d3ad | 1 | 2022-02-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643bc58-bb0e-5c79-e053-2991aa0a02ae | 2026-05-19 | Warnings | QTT17582CB |
| Clindamycin phosphate | CLINDAMYCIN PHOSPHATE | Baxter Healthcare Corporation | 1a42c3b2-90b5-4a78-9f18-fa789742b033 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 309336 309335 |
| Clindamycin phosphate | CLINDAMYCIN PHOSPHATE | Baxter Healthcare Company | 406534a6-2234-4735-ba8f-7de4c87592e6 | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 309336 309335 |
| Dextrose | DEXTROSE | B. Braun Medical Inc. | 60b6d7c3-0164-46c9-aa38-b5aa1c31a5d5 | 2026-05-12 | Warnings, Adverse reactions | LX22YL083G |
| clindamycin phosphate | CLINDAMYCIN PHOSPHATE | Baxter Healthcare Company | 44fa506b-90ac-42de-831b-5f3f1a500fc0 | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | 309336 309335 |
| Clindamycin phosphate | CLINDAMYCIN PHOSPHATE | Baxter Healthcare Company | 78832ac6-04c5-45e0-ae4d-f56d7920dda9 | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | 309336 309335 |
| Clindamycin in 5 Percent Dextrose | CLINDAMYCIN IN 5 PERCENT DEXTROSE | Civica, Inc. | 80217bd6-2bc4-401c-9345-22532b36a24f | 2026-04-24 | Boxed warning, Warnings, Adverse reactions | ANDA201692 72572-076-01 72572-074-01 72572-074-24 72572-076-24 72572-076 72572-074 72572007601 309336 309335 4711c157-19a5-4886-b468-8739876e67be 80217bd6-2bc4-401c-9345-22532b36a24f 3U02EL437C |
| DIANEAL Low Calcium with Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | aa268d3f-7389-4f25-801f-5d4825495f08 | 2026-04-16 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 99c6a1a9-cadf-435b-a332-ccc189afdfa9 | 2026-04-16 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 40fd1ac4-39bb-45fb-ba99-4fb65481f231 | 2026-04-09 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | 8e7046f8-841e-465a-af69-af9fb3d6799d | 2026-03-17 | Warnings, Adverse reactions | LX22YL083G |
| DEXTROSE | DEXTROSE | HF Acquisition Co. LLC. DBA HealthFirst | 4d2d3d3d-d96e-4005-e063-6394a90afd9a | 2026-03-16 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 3b8f2692-4371-4f1a-95af-b41842131fdd | 2026-03-13 | Warnings, Adverse reactions | LX22YL083G |
| Skin Irritations and Itch Relief | AGARICUS MUSCARIUS, ALUMINA, ANAGALLIS ARVENSIS, ANTIMONIUM TARTARICUM, APIS MELLIFICA, ARSENICUM ALBUM, ARSENICUM IODATUM, BOVISTA, CAUSTICUM, DOLICHOS PRURIENS, FAGOPYRUM ESCULENTUM, GRAPHITES, KALI MURIATICUM, MURIATICUM ACIDUM, OLEANDER, PETROLEUM, PIX LIQUIDA, RADIUM BROMATUM (12X, 30X, 1LM), RHUS TOX, SELENIUM METALLICUM, SULPHUR AND URTICA URENS. | King Bio Inc. | d139d2f1-0369-4963-9f3d-c4cc0f1ea2dd | 2026-03-10 | Warnings | QTT17582CB |
| Clindamycin in 5 Percent Dextrose | CLINDAMYCIN IN 5 PERCENT DEXTROSE | Sandoz Inc | 231d95a6-5e5f-4a45-a92b-d3d16ef0a7ca | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | ANDA201692 309336 309335 3U02EL437C |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | LX22YL083G |
| Lidocaine Hydrochloride and Dextrose | LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE | ProPharma Distribution | 48c0ee87-f722-1a71-e063-6394a90a72d1 | 2026-01-19 | Warnings, Adverse reactions | LX22YL083G |
| Lidocaine Hydrochloride and Dextrose | LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE | B. Braun Medical Inc. | 7dff29d9-522d-40eb-a9d9-42377912d640 | 2026-01-14 | Warnings, Adverse reactions | LX22YL083G |
| Endotoxin Terrain Drops 2143 | ENDOTOXIN TERRAIN DROPS | Professional Complementary Health Formulas | 58842566-005a-48b5-973d-20cde2fbd701 | 2026-01-08 | Warnings | QTT17582CB |
| Dextrose | DEXTROSE MONOHYDRATE | BECTON DICKINSON AND COMPANY | 32132016-1870-481b-9816-e11beb03ca0b | 2026-01-08 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.